IDEXX Laboratories Inc (IDXX)
418.55
-0.06
(-0.01%)
USD |
NASDAQ |
Nov 21, 16:00
428.99
+10.44
(+2.49%)
After-Hours: 04:52
IDEXX Laboratories Profit Margin (Quarterly): 23.87% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 23.87% |
| June 30, 2024 | 20.26% |
| March 31, 2024 | 24.44% |
| December 31, 2023 | 21.58% |
| September 30, 2023 | 23.18% |
| June 30, 2023 | 23.76% |
| March 31, 2023 | 23.78% |
| December 31, 2022 | 20.78% |
| September 30, 2022 | 21.50% |
| June 30, 2022 | 15.34% |
| March 31, 2022 | 23.19% |
| December 31, 2021 | 20.32% |
| September 30, 2021 | 21.62% |
| June 30, 2021 | 24.52% |
| March 31, 2021 | 26.26% |
| December 31, 2020 | 24.24% |
| September 30, 2020 | 20.26% |
| June 30, 2020 | 23.36% |
| March 31, 2020 | 17.85% |
| December 31, 2019 | 14.95% |
| September 30, 2019 | 17.98% |
| June 30, 2019 | 20.27% |
| March 31, 2019 | 17.82% |
| December 31, 2018 | 15.59% |
| September 30, 2018 | 17.10% |
| Date | Value |
|---|---|
| June 30, 2018 | 18.72% |
| March 31, 2018 | 16.64% |
| December 31, 2017 | 7.56% |
| September 30, 2017 | 14.33% |
| June 30, 2017 | 16.77% |
| March 31, 2017 | 14.94% |
| December 31, 2016 | 11.82% |
| September 30, 2016 | 12.59% |
| June 30, 2016 | 14.40% |
| March 31, 2016 | 11.02% |
| December 31, 2015 | 11.10% |
| September 30, 2015 | 10.88% |
| June 30, 2015 | 13.77% |
| March 31, 2015 | 12.18% |
| December 31, 2014 | 7.38% |
| September 30, 2014 | 13.60% |
| June 30, 2014 | 14.67% |
| March 31, 2014 | 12.93% |
| December 31, 2013 | 12.22% |
| September 30, 2013 | 13.51% |
| June 30, 2013 | 15.31% |
| March 31, 2013 | 13.51% |
| December 31, 2012 | 13.57% |
| September 30, 2012 | 13.58% |
| June 30, 2012 | 15.29% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
14.95%
Minimum
Dec 2019
26.26%
Maximum
Mar 2021
21.75%
Average
22.40%
Median
Profit Margin (Quarterly) Benchmarks
| Agilent Technologies Inc | 17.87% |
| Bio-Rad Laboratories Inc | -- |
| Regeneron Pharmaceuticals Inc | 36.03% |
| West Pharmaceutical Services Inc | 18.21% |
| NovaBay Pharmaceuticals Inc | -49.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 57.37% |
| Return on Assets | 26.30% |
| Return on Invested Capital | 35.27% |
| Gross Profit Margin (Quarterly) | 61.10% |
| Operating Margin (Quarterly) | 31.15% |
| Return on Net Operating Assets | 37.38% |